# Evaluation of Coffee Therapy for Improvement of Renal Oxygenation

> **NCT03878277** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 10 (actual)

## Conditions studied

- Type1diabetes
- Type1 Diabetes Mellitus
- Diabetic Kidney Disease
- Juvenile Diabetes
- Diabetic Nephropathies
- Diabetes Complications
- Diabetes, Autoimmune

## Interventions

- **DRUG:** Starbucks® Cold brew - 325ml bottle

## Key facts

- **NCT ID:** NCT03878277
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2020-01-21
- **Final completion:** 2021-09-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03878277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03878277, "Evaluation of Coffee Therapy for Improvement of Renal Oxygenation". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03878277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*